884 results on '"Woermann B"'
Search Results
352. Molecular Biological Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia
353. Intracellular Effects of Anthracydines: Distribution, DNA-Binding and Genotoxicity
354. Overview of Current Treatment for Acute Myeloid Leukemia
355. Chemotherapy for Acute Myeloid Leukemia: the State of the Art and the Contribution of Idarubicin
356. Fludarabine in Low-Grade Lymphoma: St. Bartholomew’s Hospital Experience
357. Potential Immunological Action of Purine Nucleoside Analogs
358. Future Role of Purine Analogues in Oncology
359. Fludarabine for the Treatment of Advanced Chronic Lymphocytic Leukemia: Results of a Prospective Randomized Comparison with Cyclophosphamide, Doxorubicin and Prednisone
360. Immunophenotypic Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia
361. Current Approaches in the Treatment of Chronic Lymphocytic Leukemia
362. Flowcytometric Detection of Aneuploidies in Acute Lymphoblastic Leukemia (ALL) Before and After Chemotherapy
363. Cytomorphology and Clinical Outcome in 80 Patients with AML M4Eo and Inversion 16
364. Studies on Plasma Coagulation in Children with ALL Undergoing Therapy Using the COALL-05-92 Protocol
365. Methods for Detection of Minimal Residual Disease
366. Prognostic Relevance of Proteolytically Inactivated Alpha1-Antitrypsin Excreted in the Urine of Patients with Acute Myeloid Leukemia
367. Adhesion Molecule Receptor Profile in Acute Leukemia
368. Expression of Adhesion Molecules on Blood Derived CD34 Positive Cells Immediately After Thawing and After Ex Vivo Incubation with Cytokines
369. CD54 Expression and Its Role in Homotypic Aggregation of the Blasts of Acute Myeloblastic (AML) and Acute Lymphoblastic Leukemia (ALL)
370. Marked Effect of the Combination of a Novel Vitamin D3 Analog, KH1060, and 9-cis-RA on Inhibition of Clonal Growth, Decreases of bcl-2 Level and Induction of Apoptosis in HL-60 Cells
371. The Influence of Short Term Liquid Culture of Leukemic Blasts on Their Phenotype
372. Monitoring Leukemic Cells During the Course of Acute Leukemia by Immunophenotyping and Genotyping
373. CD7+CD4-CD8-Blast Cells in Acute Leukemia
374. Evaluation of Chimerism After Allogeneic Bone Marrow Transplantation Using Amplification of Hypervariable Regions of Human Genome by Polymerase Chain Reaction
375. Detection of Minimal Residual Disease on Bone Marrow Smears by Reverse Transcriptase Polymerase Chain Reaction
376. BCR/ABL and Signal Transduction Pathways
377. An Alternative Transcript of the Human GM-CSF Receptor Alpha Chain Lacking the Signal Sequence Is Found in AML Blasts and Normal Controls
378. Cytokine Serum Levels During the Course of Acute Myeloid Leukemia
379. Adoptive Transfer of NK Cells Can Eradicate Residual Leukemia After BMT
380. Expression of FLT3 and FLT3 Ligand in Human Leukemia-Lymphoma Cell Lines
381. GM-CSF Dose Response Curves in Priming of AML Progenitors for Ara-C
382. Interleukins (IL-1, IL-2, IL-4, IL6) and TNF Production in Children with Acute Lymphoblastic Leukemia
383. Different Potential of G-CSF, GM-CSF, and pIXY in Priming of Myeloid Leukemic Progenitors for Ara-C
384. Insulin-Like Growth Factors and Their Specific Binding Proteins in Leukemia (ALL) and Non-Hodgkin Lymphoma
385. Truncated Granulocyte - Colony Stimulating Factor Receptors in Severe Congenital Neutropenia Terminating in Acute Myeloid Leukemia
386. Detection of the Wilms Tumor Gene (wt-1) mRNA in Complete Remission of AML Frequently Precedes Relapse
387. Homozygous Deletion of the p16 Gene in Childhood Acute Lymphoblastic Leukemia
388. Diversity of the TcR-d Gene Rearrangements Indicates Subclone Formation in Acute B Cell Precursor Leukemias
389. A Cloning Strategy to Identify Genes that Functionally Interact with Bcr-Abl for Transformation
390. Molecular Genetic Screening of Children with Acute Leukemia by RT-PCR
391. Molecular Genetic Detection of Chromosomal Abnormalities at 11q23 in Patients with De Novo and Secondary Acute Leukemia
392. Sequence Analysis of the GAP-Related Domain of the NFI-Gene and All Three RAS Protooncogenes in Patients with Secondary Acute Leukemia
393. Myelodysplastic Syndromes or Leukemia Following MDS Treated with Allogeneic Bone Marrow Transplantation: A Survey of the Working Party on Chronic Leukemia of the European Cooperative Group for Blood and Marrow Transplantation
394. Quality of Life in Patients with Acute Myeloid Leukemia - A Longitudinal Study
395. Prospective Comparison of Allogeneic Bone Marrow Transplantation, Intensive Consolidation Chemotherapy, and Unpurged Autologous Bone Marrow Transplantation as Post-Remission Therapy in Adult Acute Myeloid Leukemia
396. CDKN2 Deletions in Leukemia-Derived Cell Lines: Detection by Fluorescence In Situ Hybridization with Interphase Cells
397. Biology and Detection of t(4;11) Leukemias
398. Screening with Sensitive Detection Methods Allows a Reduction in the Incidence of Cytomegalovirus Disease After Allogeneic Bone Marrow Transplantation
399. Acyclovir and Cytomegalovirus Immunoglobulins as Prophylaxis for Cytomegalovirus Infections in Allogeneic Bone Marrow Transplant Recipients
400. Mediators in Sepsis and Septic Shock
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.